Articles

Most Men Unaware of Their Breast Cancer Risk

A study of men with a family history of breast cancer revealed that nearly 80% were unaware of their own risk for breast cancer, and all of them said that their healthcare provider had not discussed the disease with them.

TOP - Daily

Preliminary results of an ongoing trial suggest that a combination of trastuzumab, bevacizumab, and docetaxel is safe and effective as first-line therapy in women with metastatic breast cancer (MBC).

Fourteen of the 18 patients treated to date had a partial response or stable disease, a clinical benefit rate of 77.7, the investigators report.

TOP - Daily

Adding the monoclonal antibody rituximab to chemotherapy signicantly increases both progression-free and overall survival in previously untreated patients with chronic lymphocytic leukemia (CLL), the German Lymphocytic Leukaemia Study Group reports.

TOP - Daily

The recently approved taxane cabazitaxel significantly improved overall survival in men with castration-resistant prostate cancer in a multinational phase 3 study.

The TROPIC investigators found that men treated with cabazitaxel plus prednisone had 30% lower risk of death compared with patients treated with mitoxantrone plus prednisone.

TOP - Daily

Results of a trial by the Children's Oncology Group indicate that children with intermediate-risk neuroblastoma can be successfully treated with a shorter duration and lower doses of chemotherapy than are currently used.

TOP - Daily

Surgery provides excellent long-term cancer control and high survival rates for men with aggressive prostate cancer, a new study suggests.

In the study by researchers from the Mayo Clinic, Rochester, Minnesota, and Fox Chase Cancer Center, Philadelphia, men with high-risk prostate cancer who underwent radical prostatectomy had a 10-year cancer-specific survival rate of 92% and an overall survival rate of 77%.

TOP - Daily

Findings of a new study demonstrate the benefit of early referral of young women with breast cancer to reproductive specialists for fertility preservation.

The study, reported online September 27 in the Journal of Clinical Oncology, showed that referral to reproductive specialists before breast surgery increases the likelihood of obtaining a sufficient number of oocytes for fertility preservation without delaying breast cancer treatment.

TOP - Daily

Findings of a large new study point to the potentially devastating impact of a cancer diagnosis on the mental health of a patient’s partner and the importance of involving family members in treatment.

The study of Danish men showed that men whose partners were diagnosed with breast cancer were significantly more likely to be hospitalized with an affective disorder than men whose partners did not have breast cancer. The results are reported in the September 27 online edition of Cancer.

August 2010 Vol 3, No 5

The Hematology/Oncology Pharmacy Association (HOPA) New Practitioner Award recognizes a HOPA member early in his or her career who has made a significant contribution to developing or supporting clinical hematology/oncology pharmacy services. Read More ›

Nab-paclitaxel Plus Gemcitabine May Help Patients with Advanced Pancreatic Cancer

August 2010 Vol 3, No 5

WASHINGTON, DC—Nanoparticle albumin-bound paclitaxel, often referred to as nab-paclitaxel, combined with gemcitabine boosts survival when given as first-line treatment in patients with advanced pancreatic cancer, according to results released at the 101st annual meeting of the American Association for Cancer Research.

Articles

Page 274 of 288